Advertisement
Home 2015

Archives

Vyvanse (lisdexamfetamine dimesylate) has been approved by the U.S. Food and Drug Administration to treat adults with binge-eating disorder.

FDA: Vyvanse Approved for Binge-Eating Disorder

0
Patients taking Vyvanse experienced a decrease in the number of binge eating days per week
A review of the data suggests that the antiviral drug oseltamivir (Tamiflu) shortens the length of flu symptoms by about a day

Review: Oseltamivir Shortens Flu Duration by About a Day

0
And reduces the risk of flu-related complications such as pneumonia
The United States has seen more cases of measles in January than it usually does in an entire year

CDC: Measles Cases in January Top Typical Load for Entire Year

0
Spread driven largely by outbreak that started at Disney theme parks in California in December
In what could be a significant advance for personalized medicine

Obama to Launch Personalized Medicine Research Initiative

0
Asking Congress for $215 million to compile genetic data of one million Americans for study
Automated external defibrillators installed and ready for use in many public spaces can save lives when needed

FDA to Strengthen Approval Process for AEDs

0
Agency has received 72,000 reports of automated external defibrillators failing
Millions of Americans aged 65 and older fall every year

Many Seniors Not Reporting Falls to Physician

0
Fewer than half tell their doctor of fall, researcher notes
The first generic version of Nexium (esomeprazole magnesium delayed-release capsules) has been approved by the U.S. Food and Drug Administration to treat gastroesophageal reflux disease in adults and children ages 1 and older.

FDA Approves Generic Form of Nexium

0
To treat gastroesophageal reflux disease in adults and children ages 1 and older
The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

0
Bexsero is the second vaccine approved in the past three months to prevent this disease
Natpara (parathyroid hormone) has been approved by the U.S. Food and Drug Administration to control hypocalcemia among people with hypoparathyroidism.

Natpara OK’d to Treat Low Blood Calcium in Hypoparathyroidism

0
Medication recommended for use in patients for whom the potential benefits outweigh potential risk
Too many women of childbearing age take prescription opioids

CDC: Opioid Rx Prevalent in Reproductive-Aged Females

0
Experts recommend lowest effective dose for shortest amount of time + birth control